The first speaker, Dr B A Baldwin (AFRC Institute of Animal Physiology, Babraham), described neurophysiological studies in farm animals with reference to feeding behaviour and to thermoregulation. In studies of eating-related responses, recordings were made from thalamic and hypothalamic neuronal units in conscious sheep using implanted microelectrodes. Animals were tested while comfortably restrained in a canvas 'hammock' and head restraint was obtained by clamping the sheeps' horns.
Neurons in the hypothalamus demonstrated some interesting properties. Units could be detected which fired when a handful of food of any type was shown to the animal, but not in response to an empty hand or inedible object. A further class responded when food was advanced towards the mouth after being displayed and ceased to respond on contact with the mouth. Neurons were also detected which responded to chewing solid food but not to chewing of inedible objects or to swallowing a sugar solution. A loss of response by over-stimulation with a single foodstuff was demonstrated and the response was regained as a second foodstuff was then presented. If food was repeatedly offered, but the animal not allowed to eat, the response waned but it could be reactivated by allowing a single handful of food to be eaten. This could be repeated many times.
Sheep were also employed in studies of thermoregulatory behaviour. Thermodes were implanted in the preoptic region of the hypothalamus so that it would be warmed or cooled. Animals were shorn and placed in a cold chamber with access to a controlplate. Pressing the plate activated an infrared heater for 10 seconds. The rate of use ofthe heater by the animal was taken as a measure of the net effect of changes in the ambient temperature or hypothalmic thermode temperatures. Changes in the ambient temperature or in the preoptic region produced the anticipated homeostatic responses, i.e. lowering ambient temperature or cooling the hypothalamus increased the rate at which the heaters were turned on. In sheep exposed in a large chamber and permitted to operate the infrared heaters for prolonged periods the chemical control was extremely precise; doubling the wattage of the heaters halved the rate of use. In other experiments electrical stimulation of the preoptic region of the hypothalamus was shown to elicit 'heat loss' responses such as panting and vasodilation of the ears.
Dr Susan Iversen (Merck, Sharp & Dohme) spoke on behaviour and peptides. There are now about 34 known neuropeptides, most having a peripheral action as hormones and also having a different role as CNS transmitters. They have an uneven, focal distribution in the brain and spinal cord at sites which seem to have a close interrelationship with the classical neurotransmitter pathways. In particular, there seems to be correlation with the monoamine systems. Substance P, neurotensin, somatostatin and enkephalins all appear to modify dopaminergic function.
Substance P, infused into the substantia nigra and ventral tegmental areas, produces marked locomotor stimulation indistinguishable from the effect of systemic amphetamine. The increase in cortical dopamine turnover in response to stress (induced by the application of mild electrical foot shocks in rats) was abolished by infusion of substance P-specific antibodies in those areas. Both amphetamine and the stress responses are known to be mediated by dopaminergic transmission.
Neurotensin appeared to modulate the same pathways. Infusion of neurotensin attenuated the effect of dopamine stimulation of the nucleus accumbens, suggesting a neuroleptic-like action of this peptide.
Vasopressin infusion in the rat improved memory, as shown in an avoidance test for shock. The effect could not be separated from a rise in blood pressure and general arousal. It was pointed out in discussion that other pressor agents had this effect on memory. All these compounds have peripheral and central actions, so improvement in the memory might be a specific neural action or due to a general arousal effect induced by the hypertension. Promising leads to new medicines for psychiatric disorders would come from better understanding of the peptide pathways in the brain.
Mr M E Herrtage (Cambridge Veterinary School) discussed copper toxicosis in the Bedlington terrier. This breed suffers from a high incidence of an autosomal recessive condition in which there is a chronic active hepatitis associated with high levels of stored copper in the liver. It is believed that the hepatic accumulation is due to reduced biliary excretion of copper. Thus, in some respects the condition resembles Wilson's disease in man, but there are important differences. In Wilson's disease serum caeruloplasmin levels are greatly decreased, lenticular degeneration occurs and copper is deposited in the cornea (Keyser-Fleischer rings). In the canine disease caeruloplasmin is normal or elevated, neurological signs, if they occur, appear to be secondary to liver damage inducing hepatic encephalopathy, and Keyser-Fleischer rings do not occur. Indeed, in the Bedlington terrier copper did not appear to be accumulated in the CNS except in very advanced cases.
These differences led to a heated discussion as to the value of the canine disease as a model for the human condition. The apparent failure to detect Report of meeting of Section of Comparative Medicine, 20 February 1985 heterozygotes also led to some concern about extrapolation of the data across species.
Dr W F Blakemore (Cambridge Veterinary School) discussed lysosomal storage disorders, describing specific diseases in cattle and dogs. These conditions occur as autosomal recessive inherited defects and can also be acquired in certain intoxications. The enzymes are specific for intramolecular linkages rather than substrate so that a variety of partially degraded products may accumulate.
The conditions are encountered in a wide range of species; a wide range exists in the cat and the highest incidence of a single abnormality has been recorded in cattle. In New Zealand some 25% of Aberdeen Angus cattle were found to be carriers for a-mannosidosis before an effective diagnosis and control programme was instituted. Virtually all lysosomal storage disorders known in man have been recorded in animals.
Mannosidosis in Aberdeen Angus and Murray Grey cattle has provided a valuable demonstration both of heterozygote detection and elimination of a disease by detection of carriers using genetic screening. Heterozygotes had a lower than normal level of leukocyte and plasma a-mannosidase activity. Heterozygote detection is complicated by the effect of age, sex, season, husbandry conditions and levels of parasite burden. When peer groups were carefully matched as controls it was possible to eradicate the disease within 4 years by heterozygote elimination.
The effects of ingestion of Australian plants of the genus Swainsonia, which contains an inhibitor of a-mannosidase, closely mimics a-mannosidosis. Neuronal vacuolation and axonal spheroids are induced. The vacuolation regresses with removal of the plant from the diet of the animal but the spheroids were reported to persist. This aroused considerable discussion about the possible mechanism of the toxic effect.
Fucosidosis in Springer Spaniels was also described, a condition which develops at a relatively advanced age. Vacuolation of neurones, macrophages, lymphocytes and epithelial cells occurs, with foamy macrophages present in peripheral and central nervous system.
Attempts have been made to treat these conditions with bone marrow transplantation in the hope of providing a source of the absent enzyme via normal leukocytes. This has been unsuccessful because of the failure of the enzymes to cross the blood-brain barrier.
Decompression sickness in animals and man was discussed by Dr A C Palmer (Cambridge Veterinary School). Decompression sickness (DCS) could be classified into Type I (pruritus and pain in the bones and joints) and Type II (respiratory symptoms and irreversible neurological defects). Irreversible damage to the nervous system and aseptic necrosis of bone (Caisson's disease) often occur in man after chronic exposure to high pressure, for example in professional divers after four or more years. Whales are able to tolerate depths of up to 3500 feet (1050 m), apparently without harm.
Experiments on goats showed bubbles to be present in the circulation and the white matter of the spinal cord only 20 minutes after rapid decompression from a simulated dive. The spinal bubbles were clearly shown to be within dilated small vessels, though the significance of bubbles detected only after death was uncertain. After 24 hours infarcts were present, again in the white matter and also the dorsal horn. They were accompanied by haemorrhage, oedema and microthrombi and by signs of cellular reaction after 5 days. Changes were predominantly found in the cervical cord. Of 25 goats with Type I DCS, 7 had spinal cord infarcts but this was present in 20 animals out of 24 with Type II DCS.
There may be an increased risk of damage from further diving after an episode of Type II DCS; longterm behavioural changes are being recognized in professional divers.
Dr R Heywood (Huntingdon Research Centre), the final speaker, discussed and illustrated chemically induced ophthalmological disorders. The visual system is a target, both primary and secondary, of a remarkable range of chemical agents. Toxicological studies are conventionally performed in two species, a rodent and the beagle dog or a monkey species. Dr Heywood stressed the difficulties in the interpretation of animal studies in relation to man, due in the main to species differences.
The albino rat is susceptible to phototoxic retinal degeneration, which is complicated by confounding factors such as diet, temperature, age of initial exposure and pigmentation of the rat strain. The situation is further complicated by the fact that in the rat spontaneous retinal dystrophies occur. The retinal atrophies of toxic origin cannot be distinguished from light or the spontaneous retinal dystrophy.
The beagle dog has no hereditary retinopathy so that focal retinopathies (e.g. induced by phenothiazines) are easily recognized. Many drugs, such as beta-blockers, tetracyclines, glycocides and most polycyclic compounds, bind strongly to the pigmented tissue in the eye and may accumulate there. This does not induce a retinopathy and may be of little importance. In the dog, because of the presence of the tapetum, the fundus appears multicoloured at ophthalmoscopy. Striking colour changes may be induced by ethambutol, macrolide antibiotics and other drugs, but the changes are of no significance to man.
Some toxic effects are highly species-specific; for example, amiodarone induces phospholipidosis affecting the corneal epithelium in man, and though the compound induces lipid storage in a wide variety of tissues in rats and dogs (but not baboons), it does not affect the corneal epithelium in laboratory animals. Progestogens given over long periods induce colloid degeneration of the pigment epithelial layer in Rhesus monkeys, but this has not been seen in women using this class of compound in the contraceptive pill.
Damage to the optic nerve or visual pathways may leave the retina unaffected but produce visual disturbances. The optic nerve head, in those species in which it is visible, may be seen to be enlarged or to undergo atrophy. Optic neuropathies can be induced, for example by certain organophosphate pesticides. The subacute myelo-optic neuropathy induced by clioquinol has been reproduced in the beagle. Many compounds with a central action will have a visual effect. Mechanisms of ocular toxicity are in general poorly understood. In the following discussion it was noted that the ophthalmological effect for practolol was highly specific for man and that there was still no animal model.
The meeting illustrated the problems of comparison between animals and man and the possibilities for further investigation on the central nervous system. Public interest in food allergy and intolerance is becoming intense. But doctors seem, on the whole, to be unconcernedeven gastroenterologists, whose job it is to know about the system which receives and processes food. Only a handful of gastroenterologists came to the meeting on 'Food intolerance' organized by the Forum on Food and Health on 21 June 1985, which is a shame because it was an excellent symposium, well attended by people from other disciplines. Perhaps doctors are afraid of a subject which many see as a bog or quicksand. If one has to cross a bog or quicksand it is a good idea to have a map. Professor M H Lessof of Guy's Hospital, London, opened the proceedings by providing a map in the form of a lucid and succinct overview, just as he did in his book'. If this field is a bog it is largely because it lacks objective tests. Skin-prick tests can be useful but, for the provocation of food-induced symptoms,-it is now known that they are totally unreproducible2. So, in most cases, the only diagnostic test is a double-blind challenge, which is not at all easy to do. Occasionally, a rise can be shown in plasma histamine or prostaglandins, but we are a long way from having a generally applicable blood test.
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Direct toxic effects of additives and adulterants are easily understood but new aspects are constantly being discovered. Wine has been in the news with the Austrian ethylene glycol scandal, but it is not only illegal wine additives that can cause problems. Sulphur dioxide gas, or metabisulphite which releases it, is widely used as a preservative in wine, beer and some foods such as sausages, and inhaling it can provoke asthma. Indeed, in one study, drinking 4 ounces (112 ml) of white wine caused a fall in forced expiratory volume in 4 out of 24 asthmatics and symptoms in two of them3. If this became widely known in the profession, perhaps interest in food intolerance would increase! Another popular drink which can cause trouble is cow's milk. Here it is infants who bear the brunt, as we heard in a masterly talk by John Walker-Smith, Professor of Paediatric Gastroenterology at St Bartholomew's Hospital, London. The range of organs upset by cow's milk is amazingincluding the respiratory tract (nasal catarrh, bronchitis, asthma) and the skin (eczema, urticaria and angioneurotic oedema) as well as most parts of the alimentary canal. Of afflicted infants, the lucky ones are those who immediately vomit their milk or develop urticaria, because in them the diagnosis is obvious and so is the remedy. In others, milk silently damages the intestinal mucosa and the children present as cases of malabsorption or of colitis, or simply with delayed recovery from gastroenteritis.
A high index of suspicion is what the doctor needs to pick up cases of food intolerance. But he can be too suspicious, as some enthusiasts undoubtedly are.
Perhaps this is what deters the average doctor from this area: namely, the knowledge that its practitioners include cranks, if not charlatans, and that patients are often hypochondriacs.
Nevertheless, doctors must face the facts. True cases of food intolerance may not be common but neither are they rare. According to Dr J 0 Warner of the Brompton Hospital, London, about 2% of children are sensitive to cow's milk. But at least cow's milk is easily recognized and excluded. It is not so with food additives. Take the case of tartrazine (E102). This orange-coloured azo dye is used in many popular drinks and foods such as tomato soup and custard powder. A child who is fond of orange squash can easily consume 10mg of tartrazine a day, but it takes only 0.1 mg to upset a sensitive child. Tartrazine can cause rhinitis, asthma, skin rashes and behaviour disturbances. Fortunately, tartrazine sensitivity is thought to affect only 600 in every million children, but an equal number react to sunset yellow (E110) and to benzoates, a group of commonly used preservatives (E210-E219).
To avoid all these additives a diet would have to exclude many children's favourites (hot dogs, jellies, ice-creams, etc.) and it is obviously important that the treatment should not be worse than the disease. This is a problem to which attention was drawn several times during the meeting and is especially relevant when most conditions blamed on food intolerance are nuisances rather than life-threatening diseases. This is certainly true of irritable bowel syndrome which was reviewed by John Hunter, a Consultant Physician at Addenbrooke's Hospital Cambridge.
Irritable bowel syndrome (IBS) affects at least one in 7 of the population and is the commonest cause of referral to a consultant gastroenterologist4. Its symptoms are real enough -abdominal pain, altered bowel habit, bloating, rectal dissatisfaction and passage of mucus -but their pathogenesis is still obscure5. Altered motility and increased sensitivity of the gut have both been implicated, but many doctors believe that equally important factors are 0141-0768/86/ 020118-02/$02.00/0 o 1986 The Royal Society of Medicine
